APA (7th ed.) Citation

Hollnberger, J., Liu, Y., Xu, S., Chang, S., Martin, R., Manhas, S., . . . Urban, S. (2023). No virologic resistance to bulevirtide monotherapy detected in patients through 24 weeks treatment in phase II and III clinical trials for chronic hepatitis delta. Journal of hepatology, 79(3), . https://doi.org/10.1016/j.jhep.2023.04.027

Chicago Style (17th ed.) Citation

Hollnberger, Julius, et al. "No Virologic Resistance to Bulevirtide Monotherapy Detected in Patients Through 24 Weeks Treatment in Phase II and III Clinical Trials for Chronic Hepatitis Delta." Journal of Hepatology 79, no. 3 (2023). https://doi.org/10.1016/j.jhep.2023.04.027.

MLA (9th ed.) Citation

Hollnberger, Julius, et al. "No Virologic Resistance to Bulevirtide Monotherapy Detected in Patients Through 24 Weeks Treatment in Phase II and III Clinical Trials for Chronic Hepatitis Delta." Journal of Hepatology, vol. 79, no. 3, 2023, https://doi.org/10.1016/j.jhep.2023.04.027.